The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
-
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
-
Another Perspective on Radiology Worklist Delay Assertions from the Royal College of Radiologists
Other factors such as burnout, extraneous imaging orders and increasingly non-clinical tasks are key considerations when assessing reported backlogs with radiology worklists.
-
ASCO: What New Mammography Research Reveals About Allostatic Load and Breast Density in Minority Women
High allostatic load, which has been linked to an increased incidence of breast cancer and all-cause mortality, is more than twice as likely to occur in Black and Hispanic women in comparison to White women, according to mammography research presented at American Society of Clinical Oncology (ASCO) conference.
-
Diagnostic Imaging's Weekly Scan: May 25 — May 31
Catch up on the top radiology content of the past week.
-
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
-
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
In a recent interview, Jean Seely, M.D., discussed a new study showing significantly higher rates of mastectomy, chemotherapy use and breast cancer-specific death in women with symptom-detected cancer in comparison to those with screen-detected breast cancer.
-
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
-
FDA Clears Next-Generation AI Software for Portable Brain MRI
The Optive AI software, the tenth software release for the Swoop portable MRI system, reportedly offers enhanced clarity and anatomical detail for ultra-low-field MRI of the brain.